Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
furosemid 80 mg/8 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
furosemid 80 mg/8 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
filgrastim (som pegfilgrastim) 6 mg/0,6 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
filgrastim (som pegfilgrastim) 6 mg/0,6 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
fenobarbitalnatrium 60 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
fenobarbitalnatrium 60 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
natriumklorid 180 mg/20 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
natriumklorid 180 mg/20 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
metoxipolyetylenglykol-epoetin beta 200 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
metoxipolyetylenglykol-epoetin beta 200 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
fulvestrant 250 mg/5 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
fulvestrant 250 mg/5 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
jod (som jotrolan) 2,4 g/10 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
jod (som jotrolan) 2,4 g/10 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
natriumklorid 450 mg/50 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
natriumklorid 450 mg/50 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
metoxipolyetylenglykol-epoetin beta 250 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
metoxipolyetylenglykol-epoetin beta 250 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
gallamintrietjodid 80 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
gallamintrietjodid 80 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
metylprednisolonacetat 120 mg/3 ml, injektionsvätska, suspension, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
metylprednisolonacetat 120 mg/3 ml, injektionsvätska, suspension, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
bovint insulin (som bovint lösligt protaminzinkinsulin) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
bovint insulin (som bovint lösligt protaminzinkinsulin) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
somatropin (epr) 5 mg/1,5 ml, injektionsvätska, lösning, cylinderampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
somatropin (epr) 5 mg/1,5 ml, injektionsvätska, lösning, cylinderampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
natriumklorid 45 mg/5 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
natriumklorid 45 mg/5 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
metoxipolyetylenglykol-epoetin beta 50 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
metoxipolyetylenglykol-epoetin beta 50 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
pentagastrin 500 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
pentagastrin 500 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
insulin från gris (som porcint lösligt insulin) 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
insulin från gris (som porcint lösligt insulin) 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
propofol 500 mg/50 ml, injektionsvätska, emulsion, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
propofol 500 mg/50 ml, injektionsvätska, emulsion, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
dinatriumklodronat 300 mg/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
dinatriumklodronat 300 mg/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
metoxipolyetylenglykol-epoetin beta 75 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
metoxipolyetylenglykol-epoetin beta 75 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
ganirelix 250 mikrogram/0,5 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
ganirelix 250 mikrogram/0,5 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
metotrexat (som metotrexatnatrium) 5 g/200ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
metotrexat (som metotrexatnatrium) 5 g/200ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
glatirameracetat 20 mg/ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
glatirameracetat 20 mg/ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
felypressin 0,06 enheter/2 ml + prilokainhydroklorid 60 mg/2 ml, injektionsvätska, lösning, cylinderampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
2 |
felypressin 0,06 enheter/2 ml + prilokainhydroklorid 60 mg/2 ml, injektionsvätska, lösning, cylinderampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
felypressin 0,06 enheter/2 ml + prilokainhydroklorid 60 mg/2 ml, injektionsvätska, lösning, cylinderampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
felypressin 0,06 enheter/2 ml + prilokainhydroklorid 60 mg/2 ml, injektionsvätska, lösning, cylinderampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
2 |
pentazocin (som pentazocinlaktat) 30 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
pentazocin (som pentazocinlaktat) 30 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
xylometazolinhydroklorid 500 mikrogram/milliliter, näsdroppar, lösning |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
metylnaltrexonbromid 12 mg/0,6 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
metylnaltrexonbromid 12 mg/0,6 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
gentamicin (som gentamicinsulfat) 20 mg/2 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
gentamicin (som gentamicinsulfat) 20 mg/2 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
pentazocin (som pentazocinlaktat) 60 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
pentazocin (som pentazocinlaktat) 60 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
humant insulin (som kristallinsk human zinkinsulinsuspension) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
humant insulin (som kristallinsk human zinkinsulinsuspension) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
propofol 1 g/50 ml, injektionsvätska, emulsion, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
propofol 1 g/50 ml, injektionsvätska, emulsion, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
natriumhyaluronat 8,5 mg/0,85 ml, intraokulär injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
natriumhyaluronat 8,5 mg/0,85 ml, intraokulär injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
metylprednisolonacetat 40 mg/ml, injektionsvätska, suspension, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
metylprednisolonacetat 40 mg/ml, injektionsvätska, suspension, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
gentamicin (som gentamicinsulfat) 40 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
gentamicin (som gentamicinsulfat) 40 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
fenobarbitalnatrium 15 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
fenobarbitalnatrium 15 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
humant insulin (som blandad human zinkinsulinsuspension) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
humant insulin (som blandad human zinkinsulinsuspension) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
humant insulin (som humant isofaninsulin) 300 enheter/3 ml, injektionsvätska, suspension, cylinderampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
humant insulin (som humant isofaninsulin) 300 enheter/3 ml, injektionsvätska, suspension, cylinderampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
natriumhyaluronat 5,5 mg/0,55 ml, intraokulär injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
natriumhyaluronat 5,5 mg/0,55 ml, intraokulär injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
fenol 1,25 g/25 ml, olja för injektion, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
fenol 1,25 g/25 ml, olja för injektion, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
natriumnitrit 300 mg/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
natriumnitrit 300 mg/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
gentamicin (som gentamicinsulfat) 80 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
gentamicin (som gentamicinsulfat) 80 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
foskarnetnatrium 6 g/250 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
foskarnetnatrium 6 g/250 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
fenobarbitalnatrium 30 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
fenobarbitalnatrium 30 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
irinotekanhydrokloridtrihydrat 40 mg/2 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
irinotekanhydrokloridtrihydrat 40 mg/2 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
metoklopramidhydroklorid 10 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
metoklopramidhydroklorid 10 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
fenoxibensaminhydroklorid 100 mg/2 ml, infusionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
fenoxibensaminhydroklorid 100 mg/2 ml, infusionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
irinotekanhydrokloridtrihydrat 100 mg/5 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
irinotekanhydrokloridtrihydrat 100 mg/5 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
nitroglycerin 10 mg/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
nitroglycerin 10 mg/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |